Literature DB >> 2170435

Use of inactivated foot-and-mouth disease virus antigen in liquid-phase blocking ELISA.

N P Ferris1, R P Kitching, J M Oxtoby, R M Philpot, R Rendle.   

Abstract

A liquid-phase blocking ELISA is used by the World Reference Laboratory for Foot-and-Mouth Disease for the quantification of antibodies to foot-and-mouth disease virus. The potential for using inactivated FMDV antigens in the assay has been assessed by titrating bovine convalescent sera to all seven serotypes and comparing the titres obtained with live or inactivated antigens. The titres were similar indicating that either live or inactivated antigens can be used in the liquid-phase blocking ELISA. Removing the need to use live antigens in tests for FMD antibody would reduce disease security risk and widen the acceptability of kits for FMD antibody detection and assay.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2170435     DOI： 10.1016/0166-0934(90)90005-z

Source DB:  PubMed          Journal:  J Virol Methods        ISSN： 0166-0934            Impact factor:   2.014


  7 in total

1.  Differential Persistence of Foot-and-Mouth Disease Virus in African Buffalo Is Related to Virus Virulence.

Authors:  Francois Maree; Lin-Mari de Klerk-Lorist; Simon Gubbins; Fuquan Zhang; Julian Seago; Eva Pérez-Martín; Liz Reid; Katherine Scott; Louis van Schalkwyk; Roy Bengis; Bryan Charleston; Nicholas Juleff
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

2.  Detection of foot and mouth disease virus by RT-PCR and microplate hydridization assay using inactivated viral antigens.

Authors:  D Barlic-Maganja; J Grom; I Toplak; P Hostnik
Journal:  Vet Res Commun       Date:  2004-02       Impact factor: 2.459

3.  Understanding foot-and-mouth disease virus transmission biology: identification of the indicators of infectiousness.

Authors:  Margo E Chase-Topping; Ian Handel; Bartlomiej M Bankowski; Nicholas D Juleff; Debi Gibson; Sarah J Cox; Miriam A Windsor; Elizabeth Reid; Claudia Doel; Richard Howey; Paul V Barnett; Mark E J Woolhouse; Bryan Charleston
Journal:  Vet Res       Date:  2013-07-03       Impact factor: 3.683

4.  A Recombinant Adenovirus Expressing P12A and 3C Protein of the Type O Foot-and-Mouth Disease Virus Stimulates Systemic and Mucosal Immune Responses in Mice.

Authors:  Yinli Xie; Peng Gao; Zhiyong Li
Journal:  Biomed Res Int       Date:  2016-07-10       Impact factor: 3.411

5.  Development of a foot-and-mouth disease virus serotype A empty capsid subunit vaccine using silkworm (Bombyx mori) pupae.

Authors:  Zhiyong Li; Yongzhu Yi; Xiangping Yin; Yun Zhang; Ming Liu; Hang Liu; Xuerui Li; Yinü Li; Zhifang Zhang; Jixing Liu
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

6.  Interleukin-10 production at the early stage of infection with foot-and-mouth disease virus related to the likelihood of persistent infection in cattle.

Authors:  Zhidong Zhang; Claudia Doel; John B Bashiruddin
Journal:  Vet Res       Date:  2015-11-19       Impact factor: 3.683

7.  Evaluation and optimization of a conventional SPCE for FMD post-vaccination monitoring.

Authors:  Yeong-Lim Kang; Ji-Yun Jeong; Hwi-Yeon Choi; Yanhong Zhang; Yumei Liu; Ho-Jong Lee; Jong-Chul Choi; So-Hyun Lee; Beom-Joo Lee; Sang-Won Lee; Joong-Bok Lee; Ki-Hyun Cho; Seung-Yong Park
Journal:  BMC Vet Res       Date:  2018-11-28       Impact factor: 2.741
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.